Search images on Google      Product Monograph

Active Ingredients:

• idarucizumab, 50 MG/ML

DIN: 02454343

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: 5 G PER DOSE (2 X 2.5 G /50 ML)

Schedule: Prescription

Company: BOEHRINGER INGELHEIM (CANADA) LTD LTEE  –  official site

ATC:

• V03 - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO, Wiki)
• V03A - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO)
• V03AB - Antidotes (ATC, WHO)
• V03AB37 - IDARUCIZIMAB (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 50ML

 

External Links for Praxbind:

Search on Google

• Praxbind side effects
• Praxbind dosage
• idarucizumab side effects
• idarucizumab dosage

Boehringer Ingelheim (Canada) Ltd Ltee

Go to Boehringer Ingelheim website to see drug product details. Sometimes you can find praxbind photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.